Dr. Yesenia D Santiago, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4700 Sheridan St, Suite C, Hollywood, FL 33021 Phone: 954-961-3252 Fax: 954-964-6168 |
Wayne Gerald Riskin, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4700 Sheridan Street, Suite C, Hollywood, FL 33021 Phone: 954-961-3252 Fax: 954-964-6168 |
Dr. Jakob Ulfarsson, Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1610 Seagrape Way, Hollywood, FL 33019 Phone: 954-927-2522 |
Aviva Hopkins, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3868 Sheridan St, Hollywood, FL 33021 Phone: 954-962-2309 |
Frederick J A Font, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4700 Sheridan St Ste C, Hollywood, FL 33021 Phone: 954-961-3252 Fax: 954-678-3007 |
Dr. Mark Jaffe, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 9900 Stirling Rd Ste 102, Hollywood, FL 33024 Phone: 954-441-9995 Fax: 954-391-8834 |
Dr. Steve Flinkenstein, D.O. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4700 Sheridan St Ste C, Hollywood, FL 33021 Phone: 954-961-3252 Fax: 954-678-3007 |
Charles Bader Kahn, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4700 Sheridan Street, Suite C, Hollywood, FL 33021 Phone: 954-961-3252 Fax: 954-678-3007 |
News Archive
The flow of water into and out from the cell may play a crucial role in several types of cancer. Scientists at the University of Gothenburg have now found the gate that regulates the flow of water into yeast cells.
An unprecedented decade of economic demise and a population older than 80 percent of all other U.S. states is putting Michigan in a precarious spot: More aging residents needing health care with fewer resources to pay for it.
Cytos Biotechnology Ltd today announced that Novartis will discontinue the NIC002 project, which is a therapeutic vaccine candidate for the treatment of nicotine addiction.
A new post-traumatic stress disorder (PTSD) prediction tool, developed by Geisinger Health System researchers, is simple to administer and appears to outperform other screening methods, according to new findings published electronically in the August issue of the journal General Hospital Psychiatry.
› Verified 2 days ago